Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding Revolutionaries in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Senior Director, Head of FP&A, Europe will play a critical leadership role in building, scaling, and driving financial planning excellence across the European region as the company establishes its pre-commercial and launch-ready infrastructure. Reporting to the VP, Finance and Operations, Europe, this role will be responsible for designing the European FP&A framework and managing financial views, leading core planning and forecasting processes, enabling high-quality investment decisions, and developing a strong, empowered European finance organization in close partnership with Global Finance and regional leadership
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Education Level
No Education Listed
Number of Employees
501-1,000 employees